Monoclonal Antibodies Against TRAIL

Vitamins and Hormones

Volumn 67, Issue , 2004, Pages 65-79

  Liabakk, Nina Beate ^a   Espevik, Terje ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; TNFSF10 PROTEIN, HUMAN; TNFSF10 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL; CHEMISTRY; CYTOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOLOGY; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS REGULATORY PROTEINS; HUMANS; IMMUNE SYSTEM; IMMUNOASSAY; MEMBRANE GLYCOPROTEINS; MICE; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042822074     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(04)67005-1     Document Type: Article

References (50)

1. A Ashkenazi R.C Pai S Fong S Leung D.A Lawrence S.A Marsters C Blackie L Chang A.E Mcmurtrey A Hebert L DeForge I.L Koumenis D Lewis L Harris J Bussiere H Koeppen Z Shahrokh R.H Schwall Safety and antitumor activity of recombinant soluble Apo2 ligand J. Clin. Invest. 104 1999 155 162
2. G.J Atkins S Evdokiou A Labrinidis A.C.W Zannettini D.R Haynes D.M Findlay Human osteoblasts are resistant to Apo2L⧸TRAIL-mediated apoptosis Bone 31 2002 448 456
3. T.M Baetu H Kwon S Sharma N Grandvaux J Hiscott Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression J. Immunol. 167 2001 3164 3173
4. J.L Bodmer P Meier J Tschopp P Schneider Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL J. Biol. Chem. 275 2000 20632 20637
5. P Clarke S.M Meintzer S Gibson C Widmann T.P Garrington G.L Johnson K.L Tyler Reovirus-induced apoptosis is mediated by TRAIL J. Virol. 74 2000 8135 8139
6. E Cretney K Takeda H Yagita M Glaccum J.J Peschon M.J Smyth Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice J. Immunol. 168 2002 1356 1361
7. G Dorothee I Vergnon J Menez H Echchakir D Grunenwald M Kubin S Chouaib F Mami-Chouaib Tumor-infiltrating CD4+ T lymphocytes express AP02 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: Role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity J. Immunol. 169 2002 809 817
8. N.A Fanger C.R Maliszewski K Schooley T.S Griffith Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) J. Exp. Med. 190 1999 1155 1164
9. S Genc S Kizyldag K Genc H Ates N Atabey Interferon gamma and lipopolysaccharide upregulate TNF-related apoptosis-inducing ligand expression in murine microglia Immunol. Lett. 85 2003 271 274
10. T.S Griffith S.R Wiley M.Z Kubin L.M Sedger C.R Maliszewski N.A Fanger Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL J. Exp. Med. 189 1999 1343 1354
11. Ø Halaas R Vik A Ashkenazi T Espevik Lipopolysaccharide induces expression of APO2 Ligand⧸TRAIL in human monocytes and macrophages Scand. J. Immunol. 51 2000 244 250
12. L.H Han W.S Sun C.H Ma L.N Zhang S.X Liu Q Zhang L.F Gao Y.H Chen Detection of soluble TRAIL in HBV infected patients and its clinical implications World J. Gastroenterol. 8 2002 1077 1080
13. J.P Herbeuval C Lambert O Sabido M Cottier P Fournel M Dy C Genin Macrophages from cancer patients: Analysis of TRAIL, TRAIL receptors and colon tumor cell apoptosis J. Natl. Cancer. Inst. 95 2003 611 621
14. B Hilliard A Wilmen C Seidel T-S Liu R Göke Y Chen Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis J. Immunol. 166 2001 1314 1319
15. I Holen P.I Croucher F.C Hamdy C.L Eaton Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells Cancer Res. 62 2002 1619 1623
16. K Ichikawa W Liu M Fleck H Zhang L Zhao T Ohtsuka Z Wang D Liu J.D Mountz M Ohtsuki W.J Koopman R Kimberly T Zhou TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis J. Immunol. 171 2003 1061 1069
17. I Jeremias I Herr T Boehler K.M Debatin TRAIL⧸Apo-2-ligand-induced apoptosis in human T cells Eur. J. Immunol. 28 1998 143 152
18. A.C Johnsen J Haux B Steinkjer U Nonstad K Egeberg A Sundan A Ashkenazi T Espevik Regulation of Apo-2 ligand⧸TRAIL expression in NK cells—involvement in NK cell-mediated cytotoxicity Cytokine 11 1999 664 672
19. P.D Katsikis M.E Garcia-Ojeda J.F Torres-Roca I.M Tijoe C.A Smith L.A Herzenberg L.A Herzenberg Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection J. Exp. Med. 186 1997 1365 1372
20. N Kayagaki N Yamaguchi M Nakayama K Okumura H Yagita Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs J. Exp. Med. 189 1999 1451 1460
21. N Kayagaki N Yamaguchi M Abe S Hirose T Shirai K Okumura H Yagita Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL) Cell. Immunol. 219 2002 82 91
22. G Köhler C Milstein Continous cultures of fused cells secreting antibody of predefined specificity Nature 256 1975 495 497
23. D Lawrence Z Shahrokh S Marsters K Achilles D Shih B Mounho K Hillan K Totpal L Deforge P Schow J Hooley S Sherwood R Pai S Leung L Khan B Gliniak J Bussiere C.A Smith S.S Strom S Kelley J.A Fox D Thomas A Ashkenazi Differential hepatocyte toxicity of recombinant Apo2L⧸TRAIL versions Nat. Med. 7 2001 383 385
24. H Lee J.M Herndon R Barreiro T.S Griffith T.A Ferguson TRAIL: A mechanism of tumor surveillance in an immune privileged site J. Immunol. 169 2002 4739 4744
25. J.H Li N.C Kirkiles-Smith J.M McNiff J.S Pober TRAIL induces apoptosis and inflammatory gene expression in human endothelial cells J. Immunol. 171 2003 1526 1533
26. N.B Liabakk A Sundan S Torp P Aukrust S.S Frøland T Espevik Development, characterization and use of monoclonal antibodies against sTRAIL: Measurement of sTRAIL by ELISA J. Immunol. Meth. 259 2002 119 128
27. J.D Lunemann S Waiczies S Ehrlich U Wendling B Seeger T Kamradt F Zipp Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells J. Immunol. 168 2002 4881 4888
28. S.M Mariani P.H Krammer Surface expression of TRAIL⧸Apo-2 ligand in activated mouse T and B cells Eur. J. Immunol. 28 1998 1492 1498
29. S.M Mariani P.H Krammer Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage Eur. J. Immunol. 28 1998 973 982
30. M.J Martinez-Lorenzo M.A Alava S Gamen K.J Kim A Chuntharapai A Pineiro J Naval A Anel Involvement of APO2 ligand⧸TRAIL in activation-induced death of Jurkat and human peripheral blood T cells Eur. J. Immunol. 28 1998 2714 2725
31. Y Miura N Misawa N Maeda Y Inagaki Y Tanaka M Ito N Kayagaki N Yamamoto H Yagita H Mizusawa Y Koyanagi Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice J. Exp. Med. 193 2001 651 659
32. B Mundt F Kuhnel L Zender Y Paul H Tillmann C Trautwein M.P Manns S Kubicka Involvement of TRAIL and its receptors in viral hepatitis FASEB J. 17 2003 94 96
33. K Oshima N Yanase C Ibukiyama A Yamashina N Kayagaki H Yagita J Mizuguchi Involvement of TRAIL⧸TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells Cytokine 14 2001 193 201
34. R.M Pitti S.A Marsters S Ruppert C.J Donahue A Moore A Ashkenazi Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family J. Biol. Chem. 271 1996 12687 12690
35. M Plasilova J Zivny J Jelinek R Neuwirtova J Cermak E Necas L Andera T Stopka TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors Leukemia 16 2002 67 73
36. N.M Robertson J.G Zangrilli A Steplewski A Hastie R.G Lindemeyer M.A Planeta M.K Smith N Innocent A.M Musani R Pascual S Peters G Litwack Differential expression of TRAIL and TRAIL receptors in allergic asthmatics following segmental antigen challenge: Evidence for a role of TRAIL in eosinophil survival J. Immunol. 169 2002 5986 5996
37. L.M Sedger D.M Shows R.A Blanton J.J Peschon R.G Goodwin D Cosman S.R Wiley IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression J. Immunol. 163 1999 920 926
38. N Seki Y Hayakawi A.D Brooks J Wine R.H Wiltrout H Yagita J.E Tanner M.J Smyth T.J Sayers Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastasis in murine renal cancer Cancer Res. 63 2003 207 213
39. J.P Sheridan S.A Marsters R.M Pitti A Gurney M Skubatch D Baldwin L Ramakrishnan C.L Gray K Baker W.I Wood A.D Goddard P Godowski A Ashkenazi Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors Science 277 1997 818 821
40. M.J Smyth E Cretney K Takeda R.H Wiltrout L.M Sedger N Kayagaki H Yagita K Okumura Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis J. Exp. Med. 193 2001 661 670
41. K Song Y Chen R Goke A Wilmen C Seidel A Goke B Hillard Y Chen Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression J. Exp. Med. 191 2000 1095 1103
42. K Takeda M.J Smyth E Cretney Y Hayakawa N Kayagaki H Yagita K Okumura Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development J. Exp. Med. 195 2002 161 169
43. J Ursini-Siegel W Zhang A Altmeyer E.N Hatada R.K.G Do H Yagita S Chen-Kiang TRAIL⧸Apo-2 ligand induces primary plasma cell apoptosis J. Immunol. 169 2002 5505 5513
44. P.O Vidalain O Azocar B Lamouille A Astier C Rabourdin-Combe C Servet-Delprat Measles virus induces functional TRAIL production by human dendritic cells J. Virol. 74 2000 556 559
45. H Walczak R.E Miller K Ariail K Gliniak T.S Griffith M Kubin W Chin J Jones A Woodward T Le C Smith J.C.L Schuh D.H Lynch Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nat. Med. 5 1999 157 163
46. K.P Wandinger J.D Lunemann O Wengert J Bellmann-Strobl O Aktas A Weber E Grundstrøm S Ehrlich K.D Wernecke H.D Volk F Zipp TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis Lancet 361 2003 2036 2043
47. B Washburn M.A Weigand A Grosse-Wilde M Janke H Stahl E Rieser M.R Sprick V Schirrmacher H Walczak TNF-related apoptosis-inducing ligand mediates tumoricidal activity of human monocytes stimulated by Newcastle disease virus J. Immunol. 179 2003 1814 1821
48. S.R Wiley K Schooley P.J Smolak W.S Din C-P Huang J.K Nicholl G.R Sutherland T.D Smoth C Rauch C.A Smith R.G Goodwin Identification and characterization of a new member of the TNF family that induces apoptosis Immunity 3 1995 673 682
49. Y Yang I Tikhonov T.J Ruckwardt M Djavani J.C Zapata C.D Pauza M.S Salvato Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism J. Virol. 77 2003 6700 6708
50. X.D Zhang A.V Franco T Nguyen C.P Gray P Hersey Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells J. Immunol. 164 2000 3961 3970